Data as of Aug 16, 2026 · Based on 3,131,739 AI responses across 10,525 prompts · See how Parse measures this
Hearing Review is a publication covering the hearing healthcare industry, including news on hearing disorders and research. It reported that the EMA has accepted Regeneron's Otarmeni gene therapy for OTOF-related hearing loss for review, which could become the first such treatment in the EU.
Sources
hearingreview.com shapes more of what AI says about Hearing Review than any other source, at 100% of its citations.
The market map
Audiology Devices and Continuing Education →Where AI ranks Hearing Review